{"disease":{"id":"genital-infection","name":"genital infection"},"drugs":{"marketed":[{"drug_id":"cefotaxime","indication_name":"Female genital tract infection","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Claforan","generic_name":"CEFOTAXIME","company_name":"Sterimax","drug_phase":"marketed","molecular_target":"","drug_class":"Cephalosporin Antibacterial","quality_score":30,"revenue":null,"mechanism":""},{"drug_id":"ampicillin","indication_name":"Female genital tract infection","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Unasyn","generic_name":"AMPICILLIN","company_name":"Bristol-Myers Squibb","drug_phase":"marketed","molecular_target":"Transient receptor potential cation channel subfamily M member 4","drug_class":"Penicillin-class Antibacterial","quality_score":53,"revenue":null,"mechanism":""},{"drug_id":"sulbactam","indication_name":"Female genital tract infection","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Unasyn","generic_name":"SULBACTAM","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Serine beta-lactamase-like protein LACTB, mitochondrial","drug_class":"beta Lactamase Inhibitor","quality_score":49,"revenue":null,"mechanism":""},{"drug_id":"metronidazole","indication_name":"Female genital tract infection","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Metro I.V. In Plastic Container","generic_name":"METRONIDAZOLE","company_name":"Baxter","drug_phase":"marketed","molecular_target":"","drug_class":"Nitroimidazole Antimicrobial [EPC]","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"piperacillin","indication_name":"Female genital tract infection","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Pipracil","generic_name":"PIPERACILLIN","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"piperacillin","quality_score":10,"revenue":null,"mechanism":"Pipracil works by inhibiting bacterial cell wall synthesis, ultimately leading to cell lysis and death."},{"drug_id":"alatrofloxacin","indication_name":"Female genital tract infection","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"ALATROFLOXACIN","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"","drug_class":"alatrofloxacin","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"ceftriaxon","indication_name":"Female genital tract infection","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Ceftriaxon","company_name":"Centre Hospitalier Universitaire Vaudois","drug_phase":"marketed","molecular_target":"Alpha-synuclein, D-amino-acid oxidase, Penicillin-binding protein 1A","drug_class":"","quality_score":19,"revenue":null,"mechanism":null},{"drug_id":"aztreonam","indication_name":"Female genital tract infection","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Azactam","generic_name":"AZTREONAM","company_name":"Bristol-Myers Squibb","drug_phase":"marketed","molecular_target":"","drug_class":"Monobactam Antibacterial [EPC]","quality_score":10,"revenue":null,"mechanism":"Aztreonam inhibits bacterial cell wall synthesis, acting as a bactericidal agent."},{"drug_id":"ertapenem","indication_name":"Female genital tract infection","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Invanz","generic_name":"ERTAPENEM","company_name":"Merck & Co.","drug_phase":"marketed","molecular_target":"","drug_class":"Penem Antibacterial","quality_score":70,"revenue":null,"mechanism":"Invanz works by inhibiting bacterial cell wall synthesis, ultimately leading to bacterial cell death."},{"drug_id":"imipenem","indication_name":"Female genital tract infection","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Primaxin","generic_name":"IMIPENEM","company_name":"Merck Sharp & Dohme B.V.","drug_phase":"marketed","molecular_target":"","drug_class":"imipenem","quality_score":70,"revenue":null,"mechanism":"Primaxin works by inhibiting bacterial cell wall synthesis, ultimately leading to bacterial cell death."},{"drug_id":"valganciclovir","indication_name":"Congenital cytomegalovirus infection","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Valcyte","generic_name":"VALGANCICLOVIR","company_name":"Cheplapharm","drug_phase":"marketed","molecular_target":"","drug_class":"Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor","quality_score":70,"revenue":null,"mechanism":"Valcyte works by inhibiting the replication of cytomegalovirus DNA through its action as a nucleoside analog DNA polymerase inhibitor."},{"drug_id":"cefoxitin","indication_name":"Female genital tract infection","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Mefoxin In Sodium Chloride 0.9% In Plastic Container","generic_name":"CEFOXITIN","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"Cephalosporin Antibacterial","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"cefotetan","indication_name":"Female genital tract infection","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Cefotan","generic_name":"CEFOTETAN","company_name":"","drug_phase":"marketed","molecular_target":"Prostaglandin G/H synthase 2","drug_class":"Cephalosporin Antibacterial [EPC]","quality_score":60,"revenue":null,"mechanism":""},{"drug_id":"cilastatin","indication_name":"Female genital tract infection","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Primaxin","generic_name":"CILASTATIN","company_name":"Merck & Co.","drug_phase":"marketed","molecular_target":"Dipeptidase 1","drug_class":"Renal Dehydropeptidase Inhibitor","quality_score":65,"revenue":null,"mechanism":"Primaxin works by inhibiting the action of dehydropeptidase, an enzyme that breaks down certain antibiotics, thereby protecting them from degradation and allowing them to reach effective concentrations in the body."},{"drug_id":"cefalotin","indication_name":"Female genital tract infection","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Cephalotin","generic_name":"cefalotin","company_name":"Eli Lilly","drug_phase":"marketed","molecular_target":"Solute carrier family 22 member 8","drug_class":"cefalotin","quality_score":33,"revenue":null,"mechanism":""},{"drug_id":"norfloxacin","indication_name":"Female genital tract infection","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Noroxin","generic_name":"NORFLOXACIN","company_name":"","drug_phase":"marketed","molecular_target":"Gamma-aminobutyric acid receptor subunit alpha-1","drug_class":"Quinolone Antimicrobial","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"ofloxacin","indication_name":"Female genital tract infection","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Floxin","generic_name":"OFLOXACIN","company_name":"","drug_phase":"marketed","molecular_target":"Histamine H3 receptor","drug_class":"Quinolone Antimicrobial [EPC]","quality_score":65,"revenue":null,"mechanism":""},{"drug_id":"ceftriaxone","indication_name":"Female genital tract infection","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Rocephin","generic_name":"ceftriaxone","company_name":"Generic (originally Roche)","drug_phase":"marketed","molecular_target":"Alpha-synuclein, D-amino-acid oxidase, Penicillin-binding protein 1A","drug_class":"Cephalosporin antibiotic (third-generation)","quality_score":50,"revenue":null,"mechanism":""},{"drug_id":"metronidazol","indication_name":"Female genital tract infection","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Metronidazol","company_name":"University of Oslo","drug_phase":"marketed","molecular_target":"Thioredoxin reductase","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"ofloxacine","indication_name":"Female genital tract infection","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Ofloxacine","company_name":"Assistance Publique - Hôpitaux de Paris","drug_phase":"phase_3","molecular_target":"Gamma-aminobutyric acid receptor subunit alpha-2, Histamine H3 receptor, Muscarinic acetylcholine receptor M1","drug_class":"","quality_score":null,"revenue":null,"mechanism":null}],"pipeline":[{"drug_id":"valacyclovir","indication_name":"Congenital Cytomegalovirus Infection","indication_type":"pipeline","phase":"Phase 3","line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"VALACYCLOVIR","company_name":"","drug_phase":"marketed","molecular_target":"Viral DNA polymerase","drug_class":"Nucleoside analogue","quality_score":80,"revenue":null,"mechanism":"Valacyclovir is an antiviral drug that inhibits viral DNA polymerase to treat herpes simplex and varicella-zoster viruses."}],"offLabel":[],"totalMarketed":20,"totalPipeline":1},"trials":{"data":[{"nct_id":"NCT06700941","title":"Impact of HPV Vaccination Against Cervical Lesions and Genital Warts in Colombia. an Ecological Assessment","phase":"","overall_status":"COMPLETED","enrollment_count":8000000,"lead_sponsor_name":"Universidad Nacional de Colombia","has_results":false},{"nct_id":"NCT04239521","title":"The Epidemiology, Management, and the Associated Burden of Related Conditions in Alopecia Areata","phase":"","overall_status":"COMPLETED","enrollment_count":51955,"lead_sponsor_name":"Momentum Data","has_results":false},{"nct_id":"NCT04679675","title":"Self-Testing Options in the Era of Primary HPV Screening for Cervical Cancer Trial","phase":"NA","overall_status":"COMPLETED","enrollment_count":32771,"lead_sponsor_name":"Kaiser Permanente","has_results":true},{"nct_id":"NCT00543543","title":"Broad Spectrum HPV (Human Papillomavirus) Vaccine Study in 16-to 26-Year-Old Women (V503-001)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":14840,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":true},{"nct_id":"NCT04822142","title":"Congenital CYtoMEgalovirus Infection in VIEtnam (CYMEVIE)","phase":"","overall_status":"RECRUITING","enrollment_count":5000,"lead_sponsor_name":"Hanoi Obstetrics and Gynecology Hospital","has_results":false},{"nct_id":"NCT02653118","title":"Long-term Follow-up of Broad Spectrum Human Papillomavirus (HPV) Vaccine Study in Women (V503-021)","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":4453,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":false},{"nct_id":"NCT00943722","title":"A Study of V503 (A Multivalent Human Papillomavirus [HPV] L1 Virus-Like Particle [VLP] Vaccine) in Preadolescents and Adolescents (V503-002)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":3074,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":true},{"nct_id":"NCT06784687","title":"Evaluation of the Prevalence and Clinical Manifestation of SARS-CoV-2 Infection in a Population of Adult and Pediatric Patients With Congenital Heart Disease","phase":"","overall_status":"COMPLETED","enrollment_count":2376,"lead_sponsor_name":"IRCCS Azienda Ospedaliero-Universitaria di Bologna","has_results":false},{"nct_id":"NCT03786497","title":"Protecting Brains and Saving Futures - the PBSF Protocol","phase":"","overall_status":"UNKNOWN","enrollment_count":2268,"lead_sponsor_name":"Protecting Brains Saving Futures","has_results":false},{"nct_id":"NCT03158220","title":"Immunogenicity and Tolerability of Broad Spectrum Human Papillomavirus (HPV) Vaccine in Adult and Young Adult Women (V503-004)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1212,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":true},{"nct_id":"NCT01862874","title":"Efficacy and Tolerability Study of V501 in Japanese Males (V501-122)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1124,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":true},{"nct_id":"NCT02904811","title":"Prevention of Diseases Induced by Chlamydia Trachomatis","phase":"NA","overall_status":"COMPLETED","enrollment_count":1092,"lead_sponsor_name":"Assistance Publique - Hôpitaux de Paris","has_results":false},{"nct_id":"NCT04039711","title":"Evaluation of Vaginal Self-sampling Diagnostic Performances to Identify Genital Infections","phase":"NA","overall_status":"COMPLETED","enrollment_count":1028,"lead_sponsor_name":"Hôpital Européen Marseille","has_results":false},{"nct_id":"NCT06226558","title":"Long-Term Outcomes of Children With Congenital CMV in New York State","phase":"","overall_status":"RECRUITING","enrollment_count":1000,"lead_sponsor_name":"Stony Brook University","has_results":false},{"nct_id":"NCT06793605","title":"Community Burden of MG Infection","phase":"","overall_status":"RECRUITING","enrollment_count":920,"lead_sponsor_name":"Chinese University of Hong Kong","has_results":false},{"nct_id":"NCT05973487","title":"A Basket Study of Customized Autologous TCR-T Cell Therapies in Patients With Locally Advanced (Unresectable) or Metastatic Solid Tumors","phase":"PHASE1","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":840,"lead_sponsor_name":"TScan Therapeutics, Inc.","has_results":false},{"nct_id":"NCT06131749","title":"Genital Tract Infections, the Vaginal Microbiome and Gestational Age at Birth Among Pregnant Women in South Africa","phase":"","overall_status":"COMPLETED","enrollment_count":603,"lead_sponsor_name":"University of Bern","has_results":false},{"nct_id":"NCT04030949","title":"Are Rectal and Genital Chlamydia Trachomatis Infections in Women Related to Anal Sex, Autoinoculation / Contamination","phase":"","overall_status":"UNKNOWN","enrollment_count":600,"lead_sponsor_name":"Region Östergötland","has_results":false},{"nct_id":"NCT05789134","title":"Mycoplasma Genitalium Infection and Associated Antimicrobial Resistance Among HIV-infected Male in Hong Kong","phase":"","overall_status":"COMPLETED","enrollment_count":573,"lead_sponsor_name":"Chinese University of Hong Kong","has_results":false},{"nct_id":"NCT04183114","title":"Immunogenicity & Safety of Bio Farma's Measles-Rubella (MR) Vaccine in Indonesian Infants (Bridging Study)","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":540,"lead_sponsor_name":"PT Bio Farma","has_results":false},{"nct_id":"NCT05754879","title":"Diagnosis of Congenital Cytomegalovirus Infection in Newborn With Particular Risk","phase":"","overall_status":"COMPLETED","enrollment_count":479,"lead_sponsor_name":"Central Hospital, Nancy, France","has_results":false},{"nct_id":"NCT05229276","title":"Efficacy of Sternum Guard in Post Cardiac Surgery Patient","phase":"NA","overall_status":"COMPLETED","enrollment_count":414,"lead_sponsor_name":"Indonesia University","has_results":false},{"nct_id":"NCT06566677","title":"Point of Care Rapid STI Test Optimization and Validation Extension","phase":"","overall_status":"COMPLETED","enrollment_count":364,"lead_sponsor_name":"Wits RHI Research Centre Clinical Research Site","has_results":false},{"nct_id":"NCT06369220","title":"A Study of the Cobas® Liat CT/NG/MG Test Versus Current Standard Practice for Managing Participants at Increased Risk of Sexually Transmitted Infections","phase":"NA","overall_status":"COMPLETED","enrollment_count":344,"lead_sponsor_name":"Hoffmann-La Roche","has_results":false},{"nct_id":"NCT05581160","title":"Assess the Performance of Metagenomic Sequencing in the Diagnosis of STI (NGS-IST)","phase":"NA","overall_status":"COMPLETED","enrollment_count":332,"lead_sponsor_name":"Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba","has_results":false},{"nct_id":"NCT01923636","title":"Prognostic Value of Neonatal Markers for the Development of Neurosensorial Sequelae in Children Infected by Cytomegalovirus in Utero","phase":"NA","overall_status":"COMPLETED","enrollment_count":254,"lead_sponsor_name":"Assistance Publique - Hôpitaux de Paris","has_results":false},{"nct_id":"NCT02139423","title":"Diagnosis of Congenital CMV Infection in Neonates Who Failed Newborn Hearing Screening","phase":"NA","overall_status":"COMPLETED","enrollment_count":235,"lead_sponsor_name":"Assistance Publique - Hôpitaux de Paris","has_results":false},{"nct_id":"NCT04398901","title":"Neurodevelopmental Outcomes in ZIKV-Exposed Children","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":204,"lead_sponsor_name":"Children's National Research Institute","has_results":false},{"nct_id":"NCT03289260","title":"Adjuvant Anal Imiquimod Therapy in Anal HPV-lesions: AdAM-trial","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":200,"lead_sponsor_name":"Medical University Innsbruck","has_results":false},{"nct_id":"NCT04071574","title":"Comparative Study on the Efficacy of Ovarian Stimulation Protocols on the Success Rate of ICSI in Female Infertility","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":200,"lead_sponsor_name":"Lebanese University","has_results":false},{"nct_id":"NCT02946346","title":"Kinetics and Ecology of Human Papillomavirus Genital Infections in Young Women","phase":"NA","overall_status":"TERMINATED","enrollment_count":190,"lead_sponsor_name":"University Hospital, Montpellier","has_results":false},{"nct_id":"NCT03391921","title":"Vaccination Against Human Papillomavirus (HPV) With the 9-valent Vaccine in HIV-positive Women (the Papillon Study)","phase":"PHASE4","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":170,"lead_sponsor_name":"Centre Hospitalier Universitaire Saint Pierre","has_results":false},{"nct_id":"NCT06572488","title":"Non-ablative Er:YAG for Recurrent Candidiasis","phase":"NA","overall_status":"COMPLETED","enrollment_count":167,"lead_sponsor_name":"Espacio Gaspar Clinic","has_results":false},{"nct_id":"NCT03568695","title":"Detection of Chlamydia Trachomatis, Neisseria Gonorrhoeae and Mycoplasma Genitalium by Real-time Multiplex Polymerase Chain Reaction (PCR) After Pooling Pharyngeal, Anorectal and Urinary Samples","phase":"NA","overall_status":"COMPLETED","enrollment_count":166,"lead_sponsor_name":"Centre Hospitalier Régional d'Orléans","has_results":false},{"nct_id":"NCT04021628","title":"Cytomegalovirus Shedding Characteristics in Pregnant Women","phase":"","overall_status":"COMPLETED","enrollment_count":160,"lead_sponsor_name":"St George's, University of London","has_results":true},{"nct_id":"NCT03638427","title":"Screening for Cervical Intraepithelial Neoplasia Using Self-collected Menstrual Blood","phase":"","overall_status":"COMPLETED","enrollment_count":159,"lead_sponsor_name":"Stanford University","has_results":true},{"nct_id":"NCT03922594","title":"Surveillance of Zika-related Microcephaly in Sub-Saharan Africa and Asia","phase":"","overall_status":"TERMINATED","enrollment_count":150,"lead_sponsor_name":"Institut Pasteur","has_results":false},{"nct_id":"NCT07450365","title":"Evaluation of Long-term Efficacy of 4 to 6-month Course Antiviral Therapy for Neurodevelopmental Impairments Caused by Congenital Cytomegalovirus Infection","phase":"PHASE4","overall_status":"NOT_YET_RECRUITING","enrollment_count":150,"lead_sponsor_name":"Hu Bofei","has_results":false},{"nct_id":"NCT04780633","title":"PRECEDE-PROCEED Model-based Program on Genital Hygiene Behaviors","phase":"NA","overall_status":"COMPLETED","enrollment_count":120,"lead_sponsor_name":"Ataturk University","has_results":false},{"nct_id":"NCT04769167","title":"Congenital Heart Anomaly Risk in Maternal Enteroviral Infection and Diabetes","phase":"NA","overall_status":"COMPLETED","enrollment_count":114,"lead_sponsor_name":"Washington University School of Medicine","has_results":false},{"nct_id":"NCT05752019","title":"TAAI Erasmus Research Initiative to Fight CF: Monitoring Inflammation in CF Lung Disease Into a New Era","phase":"","overall_status":"COMPLETED","enrollment_count":103,"lead_sponsor_name":"Erasmus Medical Center","has_results":false},{"nct_id":"NCT03901690","title":"Betaglucin 0.2% Versus Imiquimod 5% in Treatment of Ano-genital Warts: Combined Results From Triple Blind Controlled Study","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":102,"lead_sponsor_name":"Centro de Investigaciones Medicas y Ensayos Clinicos Dr Italo Fabbri","has_results":false},{"nct_id":"NCT02576054","title":"Safety and Tolerability Study of V501 in Japanese Boys (V501-200)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":101,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":true},{"nct_id":"NCT07450703","title":"The Effect of the Health Belief Model-Based Education Given to Mothers of Children Aged 9-15 on HPV Knowledge Level and Child Vaccination","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":100,"lead_sponsor_name":"University of Gaziantep","has_results":false},{"nct_id":"NCT05113303","title":"COREV 2.0 PMCF-Study on Manual and Navigated Revision Knee Patients","phase":"","overall_status":"COMPLETED","enrollment_count":100,"lead_sponsor_name":"Aesculap AG","has_results":false},{"nct_id":"NCT06809777","title":"Comparison Between Efficacy of Topical 25%Podophyllin and Cryotherapy on Genital Warts","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":96,"lead_sponsor_name":"Sheikh Zayed Medical College","has_results":false},{"nct_id":"NCT03667703","title":"Stress Ulcer Prophylaxis Versus Placebo in Critically Ill Infants With Congenital Heart Disease","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":70,"lead_sponsor_name":"Boston Children's Hospital","has_results":false},{"nct_id":"NCT04841408","title":"Prospective, Monocentric, Interventional Study on Spontaneous Vaginal Clearance of Mycoplasma Genitalium","phase":"NA","overall_status":"COMPLETED","enrollment_count":69,"lead_sponsor_name":"University Hospital, Bordeaux","has_results":false},{"nct_id":"NCT04723381","title":"The Effect of Web Based Genital Hygiene Education Provided to Orthopedically Disabled Women","phase":"NA","overall_status":"COMPLETED","enrollment_count":62,"lead_sponsor_name":"Siirt University","has_results":false},{"nct_id":"NCT02680743","title":"Cytomegalovirus Testing and Intervention Protocol for Newborn Nursery and Newborn Intensive Care Unit","phase":"NA","overall_status":"COMPLETED","enrollment_count":60,"lead_sponsor_name":"University of Nebraska","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}